Macroscopic calcified lesion has been generally considered to be stable atheroma. In our case with coronary artery disease and a prior myocardial infarction, intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) imaging before percutaneous coronary intervention (PCI) visualized a severely calcified atheroma containing lipidic materials. Following lesion dilatation with a scoring balloon, the slow-flow phenomenon with ST-segment elevation and chest pain occurred. This case suggests that calcified plaque is not necessarily stable lesion but infrequently high-risk one which requires adjunctive management to prevent the slow-flow phenomenon during the procedure.

A 78-year-old asymptomatic gentleman with a prior inferior myocardial infarction (LVEF = 39%) was hospitalized to evaluate coronary stenosis on computed tomography. Coronary angiography identified an intermediate stenosis with severe calcification in the proximal left anterior descending artery (*Figure*[*1*](#ytz078-F1){ref-type="fig"} and [Supplementary material online](#sup1){ref-type="supplementary-material"}, *Movie SI*). Since the fractional flow reserve was 0.75 despite optimal medical therapy (aspirin 100 mg, rosuvastatin 5 mg, olmesartan 20 mg, and isosorbide dinitrate 40 mg), PCI was conducted after the commencement of clopidogrel 75 mg for 2 weeks. IVUS imaging demonstrated the presence of circumferential severe calcification (proximal and distal reference diameter were 4.0 and 3.7 mm, respectively) (*Figure*[*1*](#ytz078-F1){ref-type="fig"} and [Supplementary material online](#sup1){ref-type="supplementary-material"}, *Movie SII*). However, its maximum lipid core burden index in 4 mm (MaxLCBI~4 mm~) on NIRS imaging was 959, indicating extensive lipidic materials behind calcification (*Figure*[*1*](#ytz078-F1){ref-type="fig"} and [Supplementary material online](#sup1){ref-type="supplementary-material"}, *Movie SIII*). Since rotablator use may cause no-reflow phenomenon~,~ we performed dilatation using a 3.5 × 15 mm scoring balloon (Scoreflex NC, OrbusNeich, Hong Kong) with high-pressure inflation (18 atm) under filter-wire use (Parachute™, GoodCare, Nagoya, Japan) (*Figure*[*2*](#ytz078-F2){ref-type="fig"}). Following this procedure, no-reflow phenomenon occurred with chest pain and ST-segment elevation (troponin T level = 0.103 ng/ml) (*Figure*[*2*](#ytz078-F2){ref-type="fig"} and [Supplementary material online](#sup1){ref-type="supplementary-material"}, *Movie SIV*). A final TIMI III flow with optimal dilatation of the culprit lesion was achieved by retrieving the filter wire with intracoronary administration of 2 mg nicorandil and stent implantation (3.5 × 20 mm biodegradable polymer-coated everolimus-eluting stent: SYNERGY, Boston Scientific, Natick, MA, USA). He is uneventful for 18 months after PCI.

![Imaging of culprit lesion. Coronary angiography identified significant stenosis in the proximal of left anterior descending artery. Combined near-infrared spectroscopy/intravascular ultrasound imaging visualized the presence of lipidic component behind severe circumferential calcification (*A*--*C*). A near-infrared spectroscopy-derived chemogram illustrated that MaxLCBI~4 mm~ at the culprit lesion was 959. MaxLCBI~4 mm~ = maximum lipid core burden index in 4~ ~mm.](ytz078f1){#ytz078-F1}

![Percutaneous coronary intervention procedure. Pre-dilatation was performed using a 3.5 × 15 mm scoring balloon (Scoreflex NC, OrbusNeich, Hong Kong) under filter-wire protection use (Parachute™, GoodCare, Nagoya, Japan) (left panel). Following balloon angioplasty, filter no-reflow occurred after pre-dilatation (right panel).](ytz078f2){#ytz078-F2}

Given that calcified plaque is pathophysiologically formulated through deposition of lipidic material within vessel wall, calcified lesions can contain some amount of lipidic materials, which may affect PCI-related complications.[@ytz078-B1] These observations indicate that calcified plaque is not necessarily stable lesion but infrequently high-risk one requiring preventive management for deterioration of coronary flow. Since IVUS is not capable to visualize plaque composition behind calcification,[@ytz078-B2] this case suggests the clinical applicability of NIRS/IVUS imaging catheter to evaluate procedural risk at calcified lesions.
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